TD Cowen raised the firm’s price target on Stryker to $400 from $365 and keeps a Buy rating on the shares. The firm said Stryker is carrying strong momentum from 2023 which they think can be sustained throughout 2024. Cowen expects the company to exceed these consensus targets and be on track to reach the top end of the 2024 organic revenue growth and EPS guidance ranges.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
